Nonlinear in vitro-in vivo correlations

Advances in Experimental Medicine and Biology

Volumn 423, Issue , 1997, Pages 199-206

  Mendell Harary, Jeanne ^b   Dowell, James ^b   Bigora, Sian ^b   Piscitelli, Deborah ^b   Butler, Jackie ^b   Farrell, Colm ^b   Devane, John ^b   Young, David ^b  

^a UNIVERSITY OF MARYLAND   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; INTERMETHOD COMPARISON; MODEL; NONLINEAR SYSTEM; PHARMACEUTICS; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL ANALYSIS;

EID: 0030793251     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4684-6036-0_18     Document Type: Article

References (11)

1. Guidance for Industry: Extended release solid oral dosage forms development, evaluation and application of in vitro-in vivo correlations. FDA, Center for Drug Evaluation and Research (CEDER). July 1996
2. Guidance for Industry: Immediate release solid oral dosage forms; scale-up and post-approval changes: chemistry, manufacturing and controls, In vitro dissolution testing, and in vivo bioequivalence documentation. Center for Drug Evaluation and Research. November 1995
3. Leeson LJ. In vitro/In vivo correlations. Drug Infor J 1995; 29:903-915
4. Skoug JW, Borin MT, Fleishaker JC and Cooper AM. In vitro and in vivo evaluations of whole and half tablets of sustained-release adinazolam mesylate. Pharm Research 1991; 8:1482-1488
5. Dietrich BR, Brausse R, Benedikt G and Steinijans VW. Feasibility of in vitro/in vivo correlation in the case of a new sustained-release theophylline pellet formulation. Arz Forsch 1988; 38:1229-1237
6. Hayashi T, Ogura T and Takagishi Y. New evaluation method for in vitro/in vivo correlation of enteric-coated multiple unit dosage forms. Pharm Research 1995; 12:1333-1337
7. Mendes RW, Masih SZ and Kanumuri RR. Effect of formulation and process variables on bioequivalency of nitrofurantoin II: In vitro-in vivo correlation. J Pharm Sci 1978; 67:1616-1619
8. Benedikt G, Steinijans VW and Dietrich R. Galenical development of a new sustained-release theophylline pellet formulation for once-daily administration. Arz Forsch 1988; 38:1203-9
9. Yamaoka A, Nakagawa T, and Uno T. Application of the Akaike Information Criteria (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 1978; 6:165-175
10. Gillespsie WR. PCDCON: Deconvolution for pharmacokinetic applications. University of Texas at Austin. Austin, TX 1992
11. ADAPT II. David D'Argenio. Biomedical Simulations Resource. University of Southern California. Los Angeles, CA 1992